The delivery of locally developed COVID-19 real-time reverse transcriptase polymerase chain reaction (RT-PCR) test kits is finally moving after getting the nod from the Philippines’ Food and Drug Administration (FDA).
According to the weekly report of President Rodrigo Duterte to Congress, which was released on Monday, medical research company Manila HealthTek will be coordinating with hospitals that would receive the GenAmplify COVID-19 detection kits for proper training of their workers on using the test kits.
The GenAmplify kits, developed by local scientists from the Philippine Genome Center (PGC) and the University of the Philippines (UP)-National Institutes of Health (NIH), would serve around 27,000 tests.